Revealing Genetic Variations
ParAllele BioScience accelerated healthcare breakthroughs by providing comprehensive genetic discovery solutions to the life science research, pharmaceutical and diagnostic sectors. The company's products and services utilized a unique approach that leveraged novel biochemical processes rather than complex instrumentation to discover and analyze minute variations in the human genome. The understanding of how subtle genetic variations contribute to disease risk, prognosis and drug response helps lead to new and more effective drugs, predictive diagnosis, and the ability to better tailor therapies to individual patients.
Facts & Stats
- Founded in 2001 by a team of leading researchers from the Stanford Genome Technology Center and Uppsala University.
- ParAllele BioScience established research collaborations with multiple large pharmaceutical companies and prestigious academic and government institutions.
- Acquired by Affymetrix in October 2005.